NCT06631742 · RECRUITING

Exergaming Revolution in Dementia

This pilot trial is testing whether 12 weeks of exergaming — playing video games that require physical movement, using a platform called the Dividat Senso — improves outcomes for people already living with dementia in long-term care. It compares the exergaming group to usual care. Phase NA means this is a small early-stage pilot study designed to see if the approach is feasible and worth studying further, not a definitive test of whether it works.

You may qualify if

  • Neurocognitive disorder based on Alzheimer's Disease, Parkinson's disease, Lewy body dementia or Mixed dementia according to the criteria of the American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM 5)
  • Mini-Mental-Status-Examination (MMSE) Score of ≥5 and ≤26 out of e maximum of 30

You're excluded if

  • MMSE \<5
  • Unstable cardiovascular condition or other medical condition that does not allow for safe participation according to the recommendations of the American College of Sports Medicine
  • Planned transfer to another facility within the next 3 months
  • Acute behavioural problems

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2024-10-08

View full record on ClinicalTrials.gov

All APOE4 clinical trials